IMMX News and Press, Immix Biopharma Inc. From 01/12/22

3 Penny Stocks to Add to Your Watchlist Today With stock market futures eyeing a more positive trading day for penny stocks and blue chips, investors are excited about the near future. In the past few weeks, trading has been extremely volatile across the board. This is the result of the...

IMX-110 produced a 50% response rate after 1 cycle of treatment as a monotherapy in first-line-therapy-resistant cancer - soft tissue sarcoma (STS) mice study IMX-110 response rate surpassed standard of care doxorubicin’s response rate of 0% after 1 cycle of treatment in the sa...

Los Angeles, CA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the “Company”), a biopharmaceutical company pioneering Tissue Specific Therapeutics (TSTx) TM targeting oncology and immuno-dysregulated diseases, today ann...

2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks like 2022 will be “THE” year for biotech sector. In a recent note from Piper Sandler analyst Christopher Raymond and ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to kick off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com Many of the biggest stocks on the move today are continu...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BlueCity Holdings (NASDAQ: BLCT ) has announced a buyout offer for the company’s stock from Baoli Ma and Spriver Tech Limited. Source: Shutterstock.com Let’s dive into that news below with all the ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Immix Biopharma (NASDAQ: IMMX ) stock is taking off on Monday thanks to a Rare Pediatric Disease (RPD) designation from the U.S. Food and Drug Administration (FDA). Source: Bukhta Yurii / Shutterstock.com This...

Shares of Immix Biopharma Inc. (NASDAQ:IMMX) traded at a new 52-week high today of $8.52. This new high was reached on above average trading volume as 6.8 million shares traded hands, while the average 30-day volume is approximately 461,000 shares. Immix Biopharma Inc is a clinical-stage...

Rare Pediatric Disease Designation (“RPDD”) qualifies Immix Biopharma to receive fast track review, and a priority review voucher (“PRV”) at the time of marketing approval of IMX-110. PRV holders can benefit from an expedited six-month review of a new drug ...